Accueil » La R&D d'Unicancer » Les publications de la R&D d'Unicancer » Les publications

Publications de la R&D d'Unicancer

2018

Results of Methotrexate-Etoposide-Ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/Sarcome-09 study.

N. Gaspar et al, Eur J Cancer. 2018 Jan;88:57-66. doi: 10.1016/j.ejca.2017.09.036. Epub 2017 Nov 28.

2018

Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP.

S. Supiot et al, Oncotarget. 2018 Apr 24;9(31):22147-22157. doi: 10.18632/oncotarget.25189. eCollection 2018 Apr 24.

2018

Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer.

C. Schuurhuizen et al, J Natl Compr Canc Netw. 2018 Dec;16(12):1481-1488. doi: 10.6004/jnccn.2018.7069.

2018

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.

G. Gravis et al, Eur Urol. 2018 Jun;73(6):847-855. doi: 10.1016/j.eururo.2018.02.001. Epub 2018 Feb 21.

2018

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.

P. Lavaud et al, Eur Urol. 2018 May;73(5):696-703. doi: 10.1016/j.eururo.2017.09.022. Epub 2017 Oct 23.

2018

Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey.

E. Paillaud et al, Eur J Cancer. 2018 Nov;103:61-68. doi: 10.1016/j.ejca.2018.07.137. Epub 2018 Sep 11.

2018

Rôle des gènes de la réparation de l’ADN dans la prédisposition génétique aux cancers du sein et implication pour les tests génétiques : résultats de l’étude cas-témoins GENESIS.

Girard Elodie et al, Assises de Génétique Humaine et Médicale.

2018

Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study

Girard E. et al, BRCA Symposium.

2016

Analysing patients presenting an exceptional and unexpected response in oncology: recent initiatives [article in French]

Charles Ferté et al., ITO. 2016 Jun ; 2(3) :135-140.

2016

Equal access to innovative therapies and precision cancer care

Buzyn A et al., Nat Rev Clin Oncol. 2016 Jun;13(6):385-93